photo
Speaker

David Thomas

VICE PRESIDENT, INDUSTRY RESEARCH, BIOTECHNOLOGY INNOVATION ORGANIZATION
Washington, United States
David covers investment, R&D and alliance deal trends as well as regulatory statistics that impact policy initiatives in Washington. Prior to joining BIO, David spent over a decade in the biotech industry as a biochemist in drug discovery at Amgen, Millennium and Novartis, and later in synthetic biology at the J Craig Venter Institute. David is also a financial analyst specializing in risk-adjusted DCF models and holds the Chartered Financial analyst (CFA) designation.
Speaking In
9:00 AM - 9:45 AM (EST)
Wednesday, February 17

A new report on industry clinical success rates will be released at BIO CEO 2021. Join the…